SCHEMBL7108388

SCHEMBL7108388

Cc1ccc(-n2c(-c3cccnc3)nc3ccc(OCCCCCNC(=O)CCCCCOc4ccc5nc(-c6cccs6)n(-c6ccc(C)cc6)c5c4)cc32)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 2/20 0.39
HDAC1 Q13547 2/20 0.39
G6PD P11413 1/20 0.37
LMNA P02545 2/20 0.36
MAPK1 P28482 1/20 0.36
MAPT P10636 4/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
NPSR1 Q6W5P4 2/20 0.36
ALDH1A1 P00352 1/20 0.36
KMT2A Q03164 2/20 0.36
GAA P10253 3/20 0.35
KDM4E B2RXH2 1/20 0.35
HPGD P15428 1/20 0.35
RXFP1 Q9HBX9 1/20 0.35
ESR2 Q92731 1/20 0.35
AVPR1B P47901 2/20 0.35
AOC3 Q16853 2/20 0.35
MEN1 O00255 1/20 0.35
BRD4 O60885 1/20 0.35
HSD17B10 Q99714 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2211367 0.88 TP53 (0.43) HDAC1G6PDLMNAKMT2AGAA
SCHEMBL7108384 0.88 DPP4 (0.40) G6PDLMNAMAPK1MAPTSMN1; SMN2
SCHEMBL2211938 0.87 AOC3 (0.44) G6PDLMNAMAPTSMN1; SMN2ALDH1A1
SCHEMBL2818911 0.85 AOC3 (0.41) HDAC3HDAC1G6PDMAPTKMT2A
SCHEMBL2215788 0.84 PDE3B (0.45) G6PDMAPK1MAPTALDH1A1KMT2A
SCHEMBL2212909 0.83 PDE3B (0.45) G6PDMAPK1MAPTALDH1A1KMT2A
SCHEMBL1378151 0.82 ALDH1A1 (0.44) G6PDMAPTALDH1A1KMT2AGAA
SCHEMBL2210714 0.82 PDE3B (0.46) LMNAMAPK1MAPTSMN1; SMN2NPSR1
SCHEMBL2215682 0.82 PPARG (0.48) G6PDMAPTAOC3
SCHEMBL2213264 0.82 ALDH1A1 (0.48) LMNAMAPK1MAPTSMN1; SMN2NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030229085-A1 1-Phenyl-2-heteroaryl-substituted benzimdazole derivatives, their use for the production of pharmaceutical agents as well as pharmaceutical preparations that contain these derivatives SCHERING AKTIENGESELLSCHAFT (DE) 2003-12-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030229085-A1 1-Phenyl-2-heteroaryl-substituted benzimdazole derivatives, their use for the production of pharmaceutical agents as well as pharmaceutical preparations that contain these derivatives CD4, ICOS, NFATC1 HDAC3 212/4885HDAC1 305/4885G6PD 1144/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.